 |
|
|
|
|
|
|
| Article 1 to 10 out of 16 concerning QIAGEN N.V.
|
-
Sports Doping Researchers to Tackle Mount Everest
(05/28/2008)
In the run-up to the Olympics scientists use live mice for the first time on the "roof of the world" to develop new tests for gene doping
In the run-up to the Summer Olympics, scientists are taking an innovative approach to develop new molecular testing methods for performance manipulation on the genetic level. A team of researchers from the University of Pennsylvania is attempting to ...
-
QIAGEN and BioHelix Enter Into Licensing Agreement
(05/05/2008)
Helicase-dependent isothermal DNA amplification system provides new assay technology capabilities for QIAGEN's assay automation platforms
QIAGEN and privately held BioHelix have announced that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's proprietary Helicase Dependent Amplification technology (HDA). HDA is a versatile assay technology to ...
-
QIAGEN Enables Efforts to Eradicate Costly Cattle Disease
(04/23/2008)
Collaboration with Swiss laboratory Microsynth AG pioneers nucleic acid-based primary screening for Bovine Viral Diarrhea
QIAGEN N.V. announced that it has been awarded a contract by the Swiss life science company Microsynth AG to supply the molecular cador BVDV assays for detection of viruses causing Bovine Viral Diarrhea (BVD), one of the most widespread and costly ...
-
QIAGEN to Supply Singapore Ministry of Health with Avian Flu Surveillance Solutions
(01/09/2008)
Exclusive contract is the latest in a series of agreements with international institutions that monitor the spreading of the virus strain
QIAGEN announced that it has been awarded an exclusive contract by the Singapore Ministry of Health to supply sample preparation solutions and molecular tests for the specific detection of Influenza H5N1 viruses - better known as avian flu. For ...
-
QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products
(12/05/2007)
Assay development centre for Singapore will support QIAGEN in the market for molecular testing solutions
QIAGEN and Bio*One Capital announced that they have entered into a joint venture to establish Dx Assays Pte Ltd ("Dx Assays"). Dx Assays expects to be one of the first centres in Singapore for assay development in which molecular diagnostics for ...
-
QIAGEN and the JCSG Announce Agreement for Commercialization of Sample Technologies for Protein Crystallography
(07/23/2007)
QIAGEN N.V. has entered a strategic agreement with the Joint Center for Structural Genomics (JCSG), one of the 4 PSI Structural Genomics Production Centers, providing protein crystallographers with a new set of proven crystallization screens that ...
-
Epigenomics AG erweitert Partnerschaft mit QIAGEN N.V.
(05/31/2007)
QIAGEN erwirbt exklusive weltweite Lizenz für Epigenomics DNA-Methylierungstechnologie für die molekulardiagnostische Präanalytik
QIAGEN N.V. und Epigenomics AG gaben die Erweiterung ihrer bestehenden strategischen Partnerschaft durch ein neues Lizenzabkommen bekannt. Diese neue Zusammenarbeit erweitert das 2005 geschlossene Lizenzabkommen und gewährt QIAGEN die exklusiven ...
-
QIAGEN Signs Agreement for the Acquisition of eGene
(04/17/2007)
Strategic Transaction adds Capillary Sample Separation Technology Targeting Molecular Diagnostics and Other Applications
QIAGEN N.V. announced, that its subsidiary QIAGEN North American Holdings, Inc. has signed a definitive merger agreement with eGene, Inc. pursuant to which eGene would become a fully owned subsidiary of QIAGEN North American Holdings, Inc. eGene is ...
-
QIAGEN Significantly Expands its Portfolio of Licenses to real-time PCR
(02/16/2007)
Two New Licenses Added to Technology Portfolio targeting Molecular Diagnostics
QIAGEN N.V. announced that it has acquired licenses from Roche, as well as from Ortho Clinical Diagnostics. According to the company, these two license agreements significantly expand QIAGEN's rights to real-time polymerase chain reaction (PCR) for ...
-
QIAGEN and Pathway Diagnostics Sign Agreement to Address Biomarker Development Needs in Pharma
(01/09/2007)
QIAGEN N.V. and Pathway Diagnostics Corporation announced a co-marketing partnership. The new partnership shall allow customers in the biotechnology and pharmaceutical industries to leverage QIAGEN's sample and assay technology platforms in ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon